Proteolysis targeting chimeric (PROTAC) technology is a recently discovered technique that has profound efficacy in cancer. This approach was first…
In recent years, many pharmaceutical companies have chosen to reduce their R&D investment in chemistry, viewing synthetic chemistry more as…
Most Preclinical CROs provide studies that aim at providing information about safety and efficacy of a drug candidate before testing…
Discovering and developing a new therapeutic can take 10-15 years, on average, with costs often exceeding $1 billion. For every…
Skepticism is the cornerstone of science. Much progress has been achieved by questioning established status quo and gathering social support…
It is not unusual to observe a large number of trends affecting everyday life come in and out of vogue.…
At its core AAPharmaSyn is a science company driven by pursuit of knowledge to the benefit of our clients. We…
The following white paper outlines FDA premise and guidelines to companies aspiring to engage in manufacturing of active pharmaceutical ingredients.…